DIN 02551462 — FRUZAQLA 5 MG
FRUZAQLA is a capsule of Fruquintinib marketed by TAKEDA CANADA INC. The full Fruquintinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02551462
- Brand name
- FRUZAQLA
- Active ingredient
- Fruquintinib
- Strength
- 5 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- TAKEDA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Fruquintinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02551454 | FRUZAQLA | 1 MG | CAPSULE | TAKEDA CANADA INC | MARKETED |